Lupin Limited appoints Christoph Funke as Chief Technical Operations Officer to spearhead global pharmaceutical operations
Lupin Limited, a global leader in the pharmaceutical industry, announced today the strategic appointment of Christoph Funke to the newly created role of Chief Technical ... Read More
Switzerland-based CARBOGEN AMCIS achieves ANVISA GMP certification for Shanghai facility
In a significant achievement for Switzerland-based CARBOGEN AMCIS, a leading name in pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing, the company announced its ... Read More
Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has received final approval from the United States ... Read More
Strides Pharma Science secures FDA approval for Gabapentin tablets
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. ... Read More
Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply
Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Formulations, has announced a ... Read More
Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More
Cambrex announces $425m acquisition of American CDMO Halo Pharma
Cambrex Corporation, a leading manufacturer of small molecules and generic Active Pharmaceutical Ingredients (APIs), has announced a strategic acquisition of Halo Pharma for $425 million. ... Read More